nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—CYP1A2—Estropipate—osteoporosis	0.216	0.53	CbGbCtD
Anagrelide—CYP1A2—Conjugated Estrogens—osteoporosis	0.102	0.25	CbGbCtD
Anagrelide—CYP1A2—Estradiol—osteoporosis	0.0899	0.22	CbGbCtD
Anagrelide—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000454	0.000768	CcSEcCtD
Anagrelide—Asthenia—Estropipate—osteoporosis	0.000453	0.000766	CcSEcCtD
Anagrelide—Visual impairment—Estradiol—osteoporosis	0.000453	0.000765	CcSEcCtD
Anagrelide—Anorexia—Pamidronate—osteoporosis	0.000452	0.000764	CcSEcCtD
Anagrelide—Chest pain—Zoledronate—osteoporosis	0.000452	0.000764	CcSEcCtD
Anagrelide—Arthralgia—Zoledronate—osteoporosis	0.000452	0.000764	CcSEcCtD
Anagrelide—Myalgia—Zoledronate—osteoporosis	0.000452	0.000764	CcSEcCtD
Anagrelide—Palpitations—Conjugated Estrogens—osteoporosis	0.000451	0.000763	CcSEcCtD
Anagrelide—Insomnia—Risedronate—osteoporosis	0.000451	0.000763	CcSEcCtD
Anagrelide—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000449	0.000759	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000449	0.000758	CcSEcCtD
Anagrelide—Paraesthesia—Risedronate—osteoporosis	0.000448	0.000757	CcSEcCtD
Anagrelide—Pruritus—Estropipate—osteoporosis	0.000446	0.000755	CcSEcCtD
Anagrelide—Discomfort—Zoledronate—osteoporosis	0.000446	0.000755	CcSEcCtD
Anagrelide—Asthenia—Alendronate—osteoporosis	0.000446	0.000754	CcSEcCtD
Anagrelide—Cough—Conjugated Estrogens—osteoporosis	0.000446	0.000754	CcSEcCtD
Anagrelide—Dyspnoea—Risedronate—osteoporosis	0.000445	0.000752	CcSEcCtD
Anagrelide—Hypotension—Pamidronate—osteoporosis	0.000443	0.000749	CcSEcCtD
Anagrelide—Convulsion—Conjugated Estrogens—osteoporosis	0.000443	0.000748	CcSEcCtD
Anagrelide—Dry mouth—Zoledronate—osteoporosis	0.000442	0.000747	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000442	0.000747	CcSEcCtD
Anagrelide—Fatigue—Ethinyl Estradiol—osteoporosis	0.000441	0.000746	CcSEcCtD
Anagrelide—Pruritus—Alendronate—osteoporosis	0.00044	0.000743	CcSEcCtD
Anagrelide—Dyspepsia—Risedronate—osteoporosis	0.000439	0.000742	CcSEcCtD
Anagrelide—Eye disorder—Estradiol—osteoporosis	0.000439	0.000742	CcSEcCtD
Anagrelide—Tinnitus—Estradiol—osteoporosis	0.000438	0.00074	CcSEcCtD
Anagrelide—Constipation—Ethinyl Estradiol—osteoporosis	0.000437	0.00074	CcSEcCtD
Anagrelide—Confusional state—Zoledronate—osteoporosis	0.000437	0.000738	CcSEcCtD
Anagrelide—Cardiac disorder—Estradiol—osteoporosis	0.000436	0.000737	CcSEcCtD
Anagrelide—Arthralgia—Conjugated Estrogens—osteoporosis	0.000435	0.000735	CcSEcCtD
Anagrelide—Chest pain—Conjugated Estrogens—osteoporosis	0.000435	0.000735	CcSEcCtD
Anagrelide—Myalgia—Conjugated Estrogens—osteoporosis	0.000435	0.000735	CcSEcCtD
Anagrelide—Asthenia—Ibandronate—osteoporosis	0.000434	0.000734	CcSEcCtD
Anagrelide—Nausea—Etidronic acid—osteoporosis	0.000433	0.000733	CcSEcCtD
Anagrelide—Oedema—Zoledronate—osteoporosis	0.000433	0.000732	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000432	0.00073	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000432	0.00073	CcSEcCtD
Anagrelide—Diarrhoea—Estropipate—osteoporosis	0.000432	0.00073	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Risedronate—osteoporosis	0.000431	0.000728	CcSEcCtD
Anagrelide—Infection—Zoledronate—osteoporosis	0.00043	0.000727	CcSEcCtD
Anagrelide—Fatigue—Risedronate—osteoporosis	0.00043	0.000727	CcSEcCtD
Anagrelide—Insomnia—Pamidronate—osteoporosis	0.000429	0.000725	CcSEcCtD
Anagrelide—Pruritus—Ibandronate—osteoporosis	0.000428	0.000724	CcSEcCtD
Anagrelide—Constipation—Risedronate—osteoporosis	0.000426	0.000721	CcSEcCtD
Anagrelide—Pain—Risedronate—osteoporosis	0.000426	0.000721	CcSEcCtD
Anagrelide—Shock—Zoledronate—osteoporosis	0.000426	0.00072	CcSEcCtD
Anagrelide—Paraesthesia—Pamidronate—osteoporosis	0.000426	0.00072	CcSEcCtD
Anagrelide—Diarrhoea—Alendronate—osteoporosis	0.000425	0.000719	CcSEcCtD
Anagrelide—Asthenia—Calcitriol—osteoporosis	0.000425	0.000719	CcSEcCtD
Anagrelide—Nervous system disorder—Zoledronate—osteoporosis	0.000425	0.000718	CcSEcCtD
Anagrelide—Thrombocytopenia—Zoledronate—osteoporosis	0.000424	0.000717	CcSEcCtD
Anagrelide—Mediastinal disorder—Estradiol—osteoporosis	0.000423	0.000716	CcSEcCtD
Anagrelide—Dyspnoea—Pamidronate—osteoporosis	0.000423	0.000715	CcSEcCtD
Anagrelide—Tachycardia—Zoledronate—osteoporosis	0.000423	0.000715	CcSEcCtD
Anagrelide—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000421	0.000713	CcSEcCtD
Anagrelide—Chills—Estradiol—osteoporosis	0.000421	0.000713	CcSEcCtD
Anagrelide—Somnolence—Pamidronate—osteoporosis	0.000421	0.000713	CcSEcCtD
Anagrelide—Skin disorder—Zoledronate—osteoporosis	0.000421	0.000711	CcSEcCtD
Anagrelide—Pruritus—Calcitriol—osteoporosis	0.000419	0.000709	CcSEcCtD
Anagrelide—Hyperhidrosis—Zoledronate—osteoporosis	0.000419	0.000708	CcSEcCtD
Anagrelide—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000418	0.000707	CcSEcCtD
Anagrelide—Diarrhoea—Raloxifene—osteoporosis	0.000418	0.000707	CcSEcCtD
Anagrelide—Dyspepsia—Pamidronate—osteoporosis	0.000417	0.000706	CcSEcCtD
Anagrelide—Dizziness—Estropipate—osteoporosis	0.000417	0.000706	CcSEcCtD
Anagrelide—Oedema—Conjugated Estrogens—osteoporosis	0.000417	0.000705	CcSEcCtD
Anagrelide—Alopecia—Estradiol—osteoporosis	0.000415	0.000702	CcSEcCtD
Anagrelide—Infection—Conjugated Estrogens—osteoporosis	0.000414	0.0007	CcSEcCtD
Anagrelide—Diarrhoea—Ibandronate—osteoporosis	0.000414	0.0007	CcSEcCtD
Anagrelide—Anorexia—Zoledronate—osteoporosis	0.000413	0.000698	CcSEcCtD
Anagrelide—Decreased appetite—Pamidronate—osteoporosis	0.000412	0.000697	CcSEcCtD
Anagrelide—Dizziness—Alendronate—osteoporosis	0.000411	0.000695	CcSEcCtD
Anagrelide—Shock—Conjugated Estrogens—osteoporosis	0.00041	0.000694	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000409	0.000692	CcSEcCtD
Anagrelide—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000409	0.000691	CcSEcCtD
Anagrelide—Malnutrition—Estradiol—osteoporosis	0.000409	0.000691	CcSEcCtD
Anagrelide—Fatigue—Pamidronate—osteoporosis	0.000409	0.000691	CcSEcCtD
Anagrelide—Gastrointestinal pain—Risedronate—osteoporosis	0.000408	0.000689	CcSEcCtD
Anagrelide—Tachycardia—Conjugated Estrogens—osteoporosis	0.000407	0.000688	CcSEcCtD
Anagrelide—Urticaria—Ethinyl Estradiol—osteoporosis	0.000406	0.000687	CcSEcCtD
Anagrelide—Pain—Pamidronate—osteoporosis	0.000405	0.000685	CcSEcCtD
Anagrelide—Constipation—Pamidronate—osteoporosis	0.000405	0.000685	CcSEcCtD
Anagrelide—Diarrhoea—Calcitriol—osteoporosis	0.000405	0.000685	CcSEcCtD
Anagrelide—Skin disorder—Conjugated Estrogens—osteoporosis	0.000405	0.000685	CcSEcCtD
Anagrelide—Hypotension—Zoledronate—osteoporosis	0.000405	0.000684	CcSEcCtD
Anagrelide—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000404	0.000684	CcSEcCtD
Anagrelide—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000404	0.000684	CcSEcCtD
Anagrelide—Dizziness—Raloxifene—osteoporosis	0.000404	0.000683	CcSEcCtD
Anagrelide—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000403	0.000682	CcSEcCtD
Anagrelide—Flatulence—Estradiol—osteoporosis	0.000403	0.000681	CcSEcCtD
Anagrelide—Tension—Estradiol—osteoporosis	0.000401	0.000678	CcSEcCtD
Anagrelide—Vomiting—Estropipate—osteoporosis	0.000401	0.000678	CcSEcCtD
Anagrelide—Dizziness—Ibandronate—osteoporosis	0.0004	0.000677	CcSEcCtD
Anagrelide—Rash—Estropipate—osteoporosis	0.000398	0.000673	CcSEcCtD
Anagrelide—Dermatitis—Estropipate—osteoporosis	0.000398	0.000672	CcSEcCtD
Anagrelide—Anorexia—Conjugated Estrogens—osteoporosis	0.000397	0.000672	CcSEcCtD
Anagrelide—Nervousness—Estradiol—osteoporosis	0.000397	0.000671	CcSEcCtD
Anagrelide—Urticaria—Risedronate—osteoporosis	0.000396	0.00067	CcSEcCtD
Anagrelide—Back pain—Estradiol—osteoporosis	0.000396	0.000669	CcSEcCtD
Anagrelide—Headache—Estropipate—osteoporosis	0.000395	0.000668	CcSEcCtD
Anagrelide—Vomiting—Alendronate—osteoporosis	0.000395	0.000668	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000395	0.000667	CcSEcCtD
Anagrelide—Abdominal pain—Risedronate—osteoporosis	0.000394	0.000667	CcSEcCtD
Anagrelide—Body temperature increased—Risedronate—osteoporosis	0.000394	0.000667	CcSEcCtD
Anagrelide—Muscle spasms—Estradiol—osteoporosis	0.000393	0.000665	CcSEcCtD
Anagrelide—Rash—Alendronate—osteoporosis	0.000392	0.000663	CcSEcCtD
Anagrelide—Insomnia—Zoledronate—osteoporosis	0.000392	0.000662	CcSEcCtD
Anagrelide—Dermatitis—Alendronate—osteoporosis	0.000392	0.000662	CcSEcCtD
Anagrelide—Feeling abnormal—Pamidronate—osteoporosis	0.000391	0.000661	CcSEcCtD
Anagrelide—Hypotension—Conjugated Estrogens—osteoporosis	0.00039	0.000659	CcSEcCtD
Anagrelide—Headache—Alendronate—osteoporosis	0.000389	0.000658	CcSEcCtD
Anagrelide—Paraesthesia—Zoledronate—osteoporosis	0.000389	0.000657	CcSEcCtD
Anagrelide—Vomiting—Raloxifene—osteoporosis	0.000389	0.000657	CcSEcCtD
Anagrelide—Gastrointestinal pain—Pamidronate—osteoporosis	0.000388	0.000655	CcSEcCtD
Anagrelide—Dyspnoea—Zoledronate—osteoporosis	0.000386	0.000653	CcSEcCtD
Anagrelide—Rash—Raloxifene—osteoporosis	0.000385	0.000652	CcSEcCtD
Anagrelide—Dermatitis—Raloxifene—osteoporosis	0.000385	0.000651	CcSEcCtD
Anagrelide—Somnolence—Zoledronate—osteoporosis	0.000385	0.000651	CcSEcCtD
Anagrelide—Vomiting—Ibandronate—osteoporosis	0.000385	0.000651	CcSEcCtD
Anagrelide—Headache—Raloxifene—osteoporosis	0.000383	0.000647	CcSEcCtD
Anagrelide—Rash—Ibandronate—osteoporosis	0.000382	0.000645	CcSEcCtD
Anagrelide—Dermatitis—Ibandronate—osteoporosis	0.000381	0.000645	CcSEcCtD
Anagrelide—Dyspepsia—Zoledronate—osteoporosis	0.000381	0.000644	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00038	0.000642	CcSEcCtD
Anagrelide—Ill-defined disorder—Estradiol—osteoporosis	0.000379	0.000641	CcSEcCtD
Anagrelide—Headache—Ibandronate—osteoporosis	0.000379	0.000641	CcSEcCtD
Anagrelide—Insomnia—Conjugated Estrogens—osteoporosis	0.000377	0.000638	CcSEcCtD
Anagrelide—Vomiting—Calcitriol—osteoporosis	0.000377	0.000637	CcSEcCtD
Anagrelide—Decreased appetite—Zoledronate—osteoporosis	0.000376	0.000636	CcSEcCtD
Anagrelide—Nausea—Estropipate—osteoporosis	0.000375	0.000634	CcSEcCtD
Anagrelide—Abdominal pain—Pamidronate—osteoporosis	0.000375	0.000634	CcSEcCtD
Anagrelide—Body temperature increased—Pamidronate—osteoporosis	0.000375	0.000634	CcSEcCtD
Anagrelide—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000374	0.000633	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000374	0.000632	CcSEcCtD
Anagrelide—Rash—Calcitriol—osteoporosis	0.000373	0.000632	CcSEcCtD
Anagrelide—Fatigue—Zoledronate—osteoporosis	0.000373	0.000631	CcSEcCtD
Anagrelide—Dermatitis—Calcitriol—osteoporosis	0.000373	0.000631	CcSEcCtD
Anagrelide—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000372	0.000629	CcSEcCtD
Anagrelide—Headache—Calcitriol—osteoporosis	0.000371	0.000627	CcSEcCtD
Anagrelide—Somnolence—Conjugated Estrogens—osteoporosis	0.000371	0.000627	CcSEcCtD
Anagrelide—Pain—Zoledronate—osteoporosis	0.00037	0.000626	CcSEcCtD
Anagrelide—Constipation—Zoledronate—osteoporosis	0.00037	0.000626	CcSEcCtD
Anagrelide—Nausea—Alendronate—osteoporosis	0.000369	0.000624	CcSEcCtD
Anagrelide—Malaise—Estradiol—osteoporosis	0.000369	0.000623	CcSEcCtD
Anagrelide—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000367	0.000621	CcSEcCtD
Anagrelide—Asthenia—Ethinyl Estradiol—osteoporosis	0.000367	0.00062	CcSEcCtD
Anagrelide—Syncope—Estradiol—osteoporosis	0.000367	0.00062	CcSEcCtD
Anagrelide—Nausea—Raloxifene—osteoporosis	0.000363	0.000614	CcSEcCtD
Anagrelide—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000362	0.000613	CcSEcCtD
Anagrelide—Pruritus—Ethinyl Estradiol—osteoporosis	0.000362	0.000612	CcSEcCtD
Anagrelide—Palpitations—Estradiol—osteoporosis	0.000361	0.000611	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00036	0.000609	CcSEcCtD
Anagrelide—Fatigue—Conjugated Estrogens—osteoporosis	0.000359	0.000608	CcSEcCtD
Anagrelide—Nausea—Ibandronate—osteoporosis	0.000359	0.000608	CcSEcCtD
Anagrelide—Loss of consciousness—Estradiol—osteoporosis	0.000359	0.000608	CcSEcCtD
Anagrelide—Asthenia—Risedronate—osteoporosis	0.000358	0.000605	CcSEcCtD
Anagrelide—Feeling abnormal—Zoledronate—osteoporosis	0.000357	0.000603	CcSEcCtD
Anagrelide—Cough—Estradiol—osteoporosis	0.000357	0.000603	CcSEcCtD
Anagrelide—Pain—Conjugated Estrogens—osteoporosis	0.000357	0.000603	CcSEcCtD
Anagrelide—Constipation—Conjugated Estrogens—osteoporosis	0.000357	0.000603	CcSEcCtD
Anagrelide—Gastrointestinal pain—Zoledronate—osteoporosis	0.000354	0.000599	CcSEcCtD
Anagrelide—Hypertension—Estradiol—osteoporosis	0.000353	0.000597	CcSEcCtD
Anagrelide—Pruritus—Risedronate—osteoporosis	0.000353	0.000597	CcSEcCtD
Anagrelide—Nausea—Calcitriol—osteoporosis	0.000352	0.000595	CcSEcCtD
Anagrelide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00035	0.000592	CcSEcCtD
Anagrelide—Arthralgia—Estradiol—osteoporosis	0.000348	0.000589	CcSEcCtD
Anagrelide—Myalgia—Estradiol—osteoporosis	0.000348	0.000589	CcSEcCtD
Anagrelide—Chest pain—Estradiol—osteoporosis	0.000348	0.000589	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000346	0.000585	CcSEcCtD
Anagrelide—Urticaria—Zoledronate—osteoporosis	0.000344	0.000582	CcSEcCtD
Anagrelide—Discomfort—Estradiol—osteoporosis	0.000344	0.000582	CcSEcCtD
Anagrelide—Body temperature increased—Zoledronate—osteoporosis	0.000342	0.000579	CcSEcCtD
Anagrelide—Abdominal pain—Zoledronate—osteoporosis	0.000342	0.000579	CcSEcCtD
Anagrelide—Diarrhoea—Risedronate—osteoporosis	0.000341	0.000577	CcSEcCtD
Anagrelide—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000341	0.000576	CcSEcCtD
Anagrelide—Dry mouth—Estradiol—osteoporosis	0.00034	0.000576	CcSEcCtD
Anagrelide—Asthenia—Pamidronate—osteoporosis	0.00034	0.000575	CcSEcCtD
Anagrelide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000338	0.000572	CcSEcCtD
Anagrelide—Confusional state—Estradiol—osteoporosis	0.000336	0.000569	CcSEcCtD
Anagrelide—Pruritus—Pamidronate—osteoporosis	0.000335	0.000567	CcSEcCtD
Anagrelide—Oedema—Estradiol—osteoporosis	0.000334	0.000564	CcSEcCtD
Anagrelide—Infection—Estradiol—osteoporosis	0.000332	0.000561	CcSEcCtD
Anagrelide—Urticaria—Conjugated Estrogens—osteoporosis	0.000331	0.00056	CcSEcCtD
Anagrelide—Dizziness—Risedronate—osteoporosis	0.00033	0.000558	CcSEcCtD
Anagrelide—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00033	0.000557	CcSEcCtD
Anagrelide—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00033	0.000557	CcSEcCtD
Anagrelide—Shock—Estradiol—osteoporosis	0.000328	0.000555	CcSEcCtD
Anagrelide—Nervous system disorder—Estradiol—osteoporosis	0.000327	0.000553	CcSEcCtD
Anagrelide—Tachycardia—Estradiol—osteoporosis	0.000326	0.000551	CcSEcCtD
Anagrelide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000325	0.00055	CcSEcCtD
Anagrelide—Diarrhoea—Pamidronate—osteoporosis	0.000324	0.000548	CcSEcCtD
Anagrelide—Skin disorder—Estradiol—osteoporosis	0.000324	0.000548	CcSEcCtD
Anagrelide—Hyperhidrosis—Estradiol—osteoporosis	0.000323	0.000545	CcSEcCtD
Anagrelide—Rash—Ethinyl Estradiol—osteoporosis	0.000323	0.000545	CcSEcCtD
Anagrelide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000322	0.000545	CcSEcCtD
Anagrelide—Headache—Ethinyl Estradiol—osteoporosis	0.00032	0.000542	CcSEcCtD
Anagrelide—Vomiting—Risedronate—osteoporosis	0.000317	0.000536	CcSEcCtD
Anagrelide—Rash—Risedronate—osteoporosis	0.000314	0.000532	CcSEcCtD
Anagrelide—Dermatitis—Risedronate—osteoporosis	0.000314	0.000531	CcSEcCtD
Anagrelide—Dizziness—Pamidronate—osteoporosis	0.000313	0.00053	CcSEcCtD
Anagrelide—Headache—Risedronate—osteoporosis	0.000312	0.000528	CcSEcCtD
Anagrelide—Asthenia—Zoledronate—osteoporosis	0.000311	0.000525	CcSEcCtD
Anagrelide—Pruritus—Zoledronate—osteoporosis	0.000306	0.000518	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000304	0.000514	CcSEcCtD
Anagrelide—Nausea—Ethinyl Estradiol—osteoporosis	0.000304	0.000514	CcSEcCtD
Anagrelide—Insomnia—Estradiol—osteoporosis	0.000302	0.00051	CcSEcCtD
Anagrelide—Vomiting—Pamidronate—osteoporosis	0.000301	0.00051	CcSEcCtD
Anagrelide—Paraesthesia—Estradiol—osteoporosis	0.0003	0.000507	CcSEcCtD
Anagrelide—Asthenia—Conjugated Estrogens—osteoporosis	0.000299	0.000506	CcSEcCtD
Anagrelide—Rash—Pamidronate—osteoporosis	0.000299	0.000505	CcSEcCtD
Anagrelide—Dermatitis—Pamidronate—osteoporosis	0.000299	0.000505	CcSEcCtD
Anagrelide—Dyspnoea—Estradiol—osteoporosis	0.000298	0.000503	CcSEcCtD
Anagrelide—Headache—Pamidronate—osteoporosis	0.000297	0.000502	CcSEcCtD
Anagrelide—Somnolence—Estradiol—osteoporosis	0.000297	0.000502	CcSEcCtD
Anagrelide—Diarrhoea—Zoledronate—osteoporosis	0.000296	0.000501	CcSEcCtD
Anagrelide—Nausea—Risedronate—osteoporosis	0.000296	0.000501	CcSEcCtD
Anagrelide—Pruritus—Conjugated Estrogens—osteoporosis	0.000295	0.000499	CcSEcCtD
Anagrelide—Dyspepsia—Estradiol—osteoporosis	0.000294	0.000497	CcSEcCtD
Anagrelide—Decreased appetite—Estradiol—osteoporosis	0.00029	0.00049	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Estradiol—osteoporosis	0.000288	0.000487	CcSEcCtD
Anagrelide—Fatigue—Estradiol—osteoporosis	0.000288	0.000486	CcSEcCtD
Anagrelide—Dizziness—Zoledronate—osteoporosis	0.000286	0.000484	CcSEcCtD
Anagrelide—Pain—Estradiol—osteoporosis	0.000285	0.000483	CcSEcCtD
Anagrelide—Constipation—Estradiol—osteoporosis	0.000285	0.000483	CcSEcCtD
Anagrelide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000285	0.000482	CcSEcCtD
Anagrelide—Nausea—Pamidronate—osteoporosis	0.000282	0.000476	CcSEcCtD
Anagrelide—Dizziness—Conjugated Estrogens—osteoporosis	0.000276	0.000466	CcSEcCtD
Anagrelide—Vomiting—Zoledronate—osteoporosis	0.000275	0.000466	CcSEcCtD
Anagrelide—Feeling abnormal—Estradiol—osteoporosis	0.000275	0.000465	CcSEcCtD
Anagrelide—Rash—Zoledronate—osteoporosis	0.000273	0.000462	CcSEcCtD
Anagrelide—Gastrointestinal pain—Estradiol—osteoporosis	0.000273	0.000461	CcSEcCtD
Anagrelide—Dermatitis—Zoledronate—osteoporosis	0.000273	0.000461	CcSEcCtD
Anagrelide—Headache—Zoledronate—osteoporosis	0.000271	0.000459	CcSEcCtD
Anagrelide—Vomiting—Conjugated Estrogens—osteoporosis	0.000265	0.000448	CcSEcCtD
Anagrelide—Urticaria—Estradiol—osteoporosis	0.000265	0.000448	CcSEcCtD
Anagrelide—Abdominal pain—Estradiol—osteoporosis	0.000264	0.000446	CcSEcCtD
Anagrelide—Body temperature increased—Estradiol—osteoporosis	0.000264	0.000446	CcSEcCtD
Anagrelide—Rash—Conjugated Estrogens—osteoporosis	0.000263	0.000445	CcSEcCtD
Anagrelide—Dermatitis—Conjugated Estrogens—osteoporosis	0.000263	0.000444	CcSEcCtD
Anagrelide—Headache—Conjugated Estrogens—osteoporosis	0.000261	0.000442	CcSEcCtD
Anagrelide—Nausea—Zoledronate—osteoporosis	0.000257	0.000435	CcSEcCtD
Anagrelide—Nausea—Conjugated Estrogens—osteoporosis	0.000248	0.000419	CcSEcCtD
Anagrelide—Asthenia—Estradiol—osteoporosis	0.000239	0.000405	CcSEcCtD
Anagrelide—Pruritus—Estradiol—osteoporosis	0.000236	0.000399	CcSEcCtD
Anagrelide—Diarrhoea—Estradiol—osteoporosis	0.000228	0.000386	CcSEcCtD
Anagrelide—Dizziness—Estradiol—osteoporosis	0.000221	0.000373	CcSEcCtD
Anagrelide—Vomiting—Estradiol—osteoporosis	0.000212	0.000359	CcSEcCtD
Anagrelide—Rash—Estradiol—osteoporosis	0.00021	0.000356	CcSEcCtD
Anagrelide—Dermatitis—Estradiol—osteoporosis	0.00021	0.000355	CcSEcCtD
Anagrelide—Headache—Estradiol—osteoporosis	0.000209	0.000353	CcSEcCtD
Anagrelide—Nausea—Estradiol—osteoporosis	0.000198	0.000335	CcSEcCtD
